427 related articles for article (PubMed ID: 28624396)
1. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
[TBL] [Abstract][Full Text] [Related]
3. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis.
Trivieri MG; Robson PM; Vergani V; LaRocca G; Romero-Daza AM; Abgral R; Devesa A; Azoulay LD; Karakatsanis NA; Parikh A; Panagiota C; Palmisano A; DePalo L; Chang HL; Rothstein JH; Fayad RA; Miller MA; Fuster V; Narula J; Dweck MR; Morgenthau A; Jacobi A; Padilla M; Kovacic JC; Fayad ZA
JACC Cardiovasc Imaging; 2024 Apr; 17(4):411-424. PubMed ID: 38300202
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of fusion
Okune M; Yasuda M; Soejima N; Kagioka Y; Kakehi K; Kawamura T; Hanaoka K; Kaida H; Ishii K; Nakazawa G; Miyazaki S; Iwanaga Y
J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
[TBL] [Abstract][Full Text] [Related]
7. Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography.
Chan AT; Fox J; Perez Johnston R; Kim J; Brouwer LR; Grizzard J; Kim RJ; Matasar M; Shia J; Moskowitz CS; Steingart R; Weinsaft JW
J Am Heart Assoc; 2019 May; 8(10):e011709. PubMed ID: 31072171
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis.
Sgard B; Brillet PY; Bouvry D; Djelbani S; Nunes H; Meune C; Valeyre D; Soussan M
Clin Radiol; 2019 Jan; 74(1):81.e9-81.e18. PubMed ID: 30482560
[TBL] [Abstract][Full Text] [Related]
9. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
10. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
Wisenberg G; Thiessen JD; Pavlovsky W; Butler J; Wilk B; Prato FS
J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics of Late Gadolinium Enhancement in Patients with Cardiac Sarcoidosis.
Matsumoto K; Ehara S; Sakaguchi M; Otsuka K; Hasegawa T; Shimada K; Yoshiyama M
Osaka City Med J; 2015 Jun; 61(1):9-17. PubMed ID: 26434101
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T
JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
[TBL] [Abstract][Full Text] [Related]
13. Hybrid Positron Emission Tomography/Magnetic Resonance Imaging in Arrhythmic Mitral Valve Prolapse.
Miller MA; Adams DH; Pandis D; Robson PM; Pawale A; Pyzik R; Liao SL; El-Eshmawi A; Boateng P; Garg J; Waterford S; Weiner MM; Dukkipati SR; Reddy VY; Fayad ZA; Trivieri MG
JAMA Cardiol; 2020 Sep; 5(9):1000-1005. PubMed ID: 32936270
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/
Tanaka TD; Nagai T; Nagoshi T; Yoshimura M
J Nucl Cardiol; 2020 Dec; 27(6):2149-2153. PubMed ID: 31773564
[TBL] [Abstract][Full Text] [Related]
15. Focal Myocardial Damage in Cardiac Sarcoidosis Characterized by Strain Analysis on Magnetic Resonance Tagged Imaging in Comparison with Fluorodeoxyglucose Positron Emission Tomography Accumulation and Magnetic Resonance Late Gadolinium Enhancement.
Watanabe Y; Nishii T; Shimoyama S; Ito T; Mori S; Kono AK; Takahashi S; Hirata KI; Sugimura K
J Comput Assist Tomogr; 2018; 42(4):607-613. PubMed ID: 29613987
[TBL] [Abstract][Full Text] [Related]
16. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
Lu Y; Grant C; Xie K; Sweiss NJ
Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
Sperry BW; Tamarappoo BK; Oldan JD; Javed O; Culver DA; Brunken R; Cerqueira MD; Hachamovitch R
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747
[TBL] [Abstract][Full Text] [Related]
19. Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.
Zandieh S; Bernt R; Mirzaei S; Haller J; Hergan K
J Nucl Cardiol; 2018 Aug; 25(4):1128-1134. PubMed ID: 27604109
[TBL] [Abstract][Full Text] [Related]
20. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
Gowani Z; Habibi M; Okada DR; Smith J; Derakhshan A; Zimmerman SL; Misra S; Gilotra NA; Berger RD; Calkins H; Tandri H; Chrispin J
Am J Cardiol; 2020 Nov; 134():123-129. PubMed ID: 32950203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]